Elix Provides AI Drug Discovery Platform to KYORIN Pharmaceutical

August 21, 2025
Elix, Inc. has announced that KYORIN Pharmaceutical Co., Ltd. has adopted its AI-powered drug discovery platform, Elix Discovery™, to enhance drug research and development.

Elix, Inc. has announced that KYORIN Pharmaceutical Co., Ltd. has adopted its AI-powered drug discovery platform, Elix Discovery™. This platform is designed to streamline the drug discovery process by utilizing AI technologies for molecular design and compound profiling.

Elix Discovery™ features an intuitive graphical user interface that allows users to build predictive models for optimal compound profiling. It supports both ligand-based and structure-based drug design, incorporating tools like docking simulations to enhance the drug discovery process.

The collaboration aims to accelerate KYORIN's research and improve its quality by integrating AI-driven drug discovery with KYORIN's existing capabilities. This partnership reflects a growing trend in the pharmaceutical industry to leverage AI technologies to address challenges such as long development timelines and high R&D costs.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

08/21
Artera Achieves FedRAMP High 'In Process' Status for Federal Agencies
08/21
Ginkgo Bioworks Partners with Inductive Bio and Tangible Scientific for AI-Driven Drug Discovery
08/21
LookDeep Health Introduces Aimee: AI Assistant for Hospitals
08/20
TNO Launches Motion Comfort Institute for Automated Vehicles
08/20
Convoke Secures $8.6M to Develop AI Operating System for Biopharma

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

Superagency in the Workplace: Empowering People to Unlock AI’s Full Potential

This report explores the transformative potential of artificial intelligence in the workplace, emphasizing the readiness of employees versus the slower adaptation of leadership. It highlights the significant productivity growth potential AI offers, akin to historical technological shifts, and discusses the barriers to achieving AI maturity within organizations. The report also examines the role of leadership in steering companies towards effective AI integration and the need for strategic investments to harness AI's full capabilities.

Read more

You May Also Like